[1]
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 171: Management of Preterm Labor. Obstetrics and gynecology. 2016 Oct:128(4):e155-64. doi: 10.1097/AOG.0000000000001711. Epub
[PubMed PMID: 27661654]
[2]
Dagklis T, Akolekar R, Villalain C, Tsakiridis I, Kesrouani A, Tekay A, Plasencia W, Wellmann S, Kusuda S, Jekova N, Prefumo F, Volpe N, Chaveeva P, Allegaert K, Khalil A, Sen C. Management of preterm labor: Clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation. European journal of obstetrics, gynecology, and reproductive biology. 2023 Dec:291():196-205. doi: 10.1016/j.ejogrb.2023.10.013. Epub 2023 Oct 10
[PubMed PMID: 37913556]
Level 1 (high-level) evidence
[3]
Waks AB, Martinez-King LC, Santiago G, Laurent LC, Jacobs MB. Developing a risk profile for spontaneous preterm birth and short interval to delivery among patients with threatened preterm labor. American journal of obstetrics & gynecology MFM. 2022 Nov:4(6):100727. doi: 10.1016/j.ajogmf.2022.100727. Epub 2022 Aug 19
[PubMed PMID: 35995363]
[4]
Dagklis T, Sen C, Tsakiridis I, Villalaín C, Allegaert K, Wellmann S, Kusuda S, Serra B, Sanchez Luna M, Huertas E, Volpe N, Ayala R, Jekova N, Grunebaum A, Stanojevic M. The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation. Journal of perinatal medicine. 2022 May 25:50(4):375-385. doi: 10.1515/jpm-2022-0066. Epub 2022 Mar 11
[PubMed PMID: 35285217]
Level 1 (high-level) evidence
[5]
Hoffman MK. Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234. Obstetrics and gynecology. 2021 Dec 1:138(6):945-946. doi: 10.1097/AOG.0000000000004612. Epub
[PubMed PMID: 34794160]
[6]
Hall M, Valencia CM, Soma-Pillay P, Luyt K, Jacobsson B, Shennan A, FIGO Preterm Birth Committee. Effective and simple interventions to improve outcomes for preterm infants worldwide: The FIGO PremPrep-5 initiative. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2024 Jun:165(3):929-935. doi: 10.1002/ijgo.15269. Epub 2024 Jan 24
[PubMed PMID: 38264849]
[7]
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet (London, England). 2008 Jan 5:371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4. Epub
[PubMed PMID: 18177778]
[8]
Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science (New York, N.Y.). 2014 Aug 15:345(6198):760-5. doi: 10.1126/science.1251816. Epub 2014 Aug 14
[PubMed PMID: 25124429]
[9]
Preston M, Hall M, Shennan A, Story L. The role of placental insufficiency in spontaneous preterm birth: A literature review. European journal of obstetrics, gynecology, and reproductive biology. 2024 Apr:295():136-142. doi: 10.1016/j.ejogrb.2024.02.020. Epub 2024 Feb 10
[PubMed PMID: 38359634]
[10]
Sen C. Preterm labor and preterm birth. Journal of perinatal medicine. 2017 Nov 27:45(8):911-913. doi: 10.1515/jpm-2017-0298. Epub
[PubMed PMID: 29055176]
[11]
Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG : an international journal of obstetrics and gynaecology. 2006 Dec:113 Suppl 3(Suppl 3):17-42
[PubMed PMID: 17206962]
[12]
O'Hara S, Zelesco M, Sun Z. Cervical length for predicting preterm birth and a comparison of ultrasonic measurement techniques. Australasian journal of ultrasound in medicine. 2013 Aug:16(3):124-134. doi: 10.1002/j.2205-0140.2013.tb00100.x. Epub 2015 Dec 31
[PubMed PMID: 28191186]
[13]
Ohuma EO, Moller AB, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, Okwaraji YB, Mahanani WR, Johansson EW, Lavin T, Fernandez DE, Domínguez GG, de Costa A, Cresswell JA, Krasevec J, Lawn JE, Blencowe H, Requejo J, Moran AC. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet (London, England). 2023 Oct 7:402(10409):1261-1271. doi: 10.1016/S0140-6736(23)00878-4. Epub
[PubMed PMID: 37805217]
Level 1 (high-level) evidence
[14]
Mensah NA, Fassett MJ, Shi JM, Kawatkar AA, Xie F, Chiu VY, Yeh M, Avila CC, Khadka N, Sacks DA, Getahun D. Examining recent trends in spontaneous and iatrogenic preterm birth across race and ethnicity in a large managed care population. American journal of obstetrics and gynecology. 2023 Jun:228(6):736.e1-736.e15. doi: 10.1016/j.ajog.2022.11.1288. Epub 2022 Nov 18
[PubMed PMID: 36403861]
[15]
Oner C, Schatz F, Kizilay G, Murk W, Buchwalder LF, Kayisli UA, Arici A, Lockwood CJ. Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. The Journal of clinical endocrinology and metabolism. 2008 Jan:93(1):252-9
[PubMed PMID: 17940116]
[16]
Gomez-Lopez N, Galaz J, Miller D, Farias-Jofre M, Liu Z, Arenas-Hernandez M, Garcia-Flores V, Shaffer Z, Greenberg JM, Theis KR, Romero R. The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal-fetal homeostasis. Reproduction (Cambridge, England). 2022 Jun 20:164(2):R11-R45. doi: 10.1530/REP-22-0046. Epub 2022 Jun 20
[PubMed PMID: 35559791]
[17]
DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. American journal of obstetrics and gynecology. 2013 Mar:208(3):233.e1-6. doi: 10.1016/j.ajog.2012.12.015. Epub 2012 Dec 12
[PubMed PMID: 23246314]
Level 1 (high-level) evidence
[18]
Creswell L, Rolnik DL, Lindow SW, O'Gorman N. Preterm Birth: Screening and Prediction. International journal of women's health. 2023:15():1981-1997. doi: 10.2147/IJWH.S436624. Epub 2023 Dec 21
[PubMed PMID: 38146587]
[19]
Yılmaz Semerci S, Yücel B, Erbas IM, Gunkaya OS, Talmac M, Çetinkaya M. The utility of amniotic fluid pH and electrolytes for prediction of neonatal respiratory disorders. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2020 Jan:33(2):253-257. doi: 10.1080/14767058.2018.1488961. Epub 2018 Jul 22
[PubMed PMID: 30033781]
[20]
Riedewald S, Kreutzmann IM, Heinze T, Saling E. Vaginal and cervical pH in normal pregnancy and pregnancy complicated by preterm labor. Journal of perinatal medicine. 1990:18(3):181-6
[PubMed PMID: 2384841]
[21]
Cousins LM, Smok DP, Lovett SM, Poeltler DM. AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. American journal of perinatology. 2005 Aug:22(6):317-20
[PubMed PMID: 16118720]
[22]
Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstetrics and gynecology. 2007 Mar:109(3):634-40
[PubMed PMID: 17329514]
[23]
Thomasino T, Levi C, Draper M, Neubert AG. Diagnosing rupture of membranes using combination monoclonal/polyclonal immunologic protein detection. The Journal of reproductive medicine. 2013 May-Jun:58(5-6):187-94
[PubMed PMID: 23763001]
[24]
. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstetrics and gynecology. 2020 Feb:135(2):e51-e72. doi: 10.1097/AOG.0000000000003668. Epub
[PubMed PMID: 31977795]
Level 3 (low-level) evidence
[25]
Prodan N, Wagner P, Sonek J, Abele H, Hoopmann M, Kagan KO. Single and repeat cervical-length measurement in twin gestation with threatened preterm labor. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2020 Apr:55(4):496-501. doi: 10.1002/uog.20306. Epub
[PubMed PMID: 31066097]
[26]
Gomez R, Romero R, Medina L, Nien JK, Chaiworapongsa T, Carstens M, González R, Espinoza J, Iams JD, Edwin S, Rojas I. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. American journal of obstetrics and gynecology. 2005 Feb:192(2):350-9
[PubMed PMID: 15695971]
[27]
McLaren JS, Hezelgrave NL, Ayubi H, Seed PT, Shennan AH. Prediction of spontaneous preterm birth using quantitative fetal fibronectin after recent sexual intercourse. American journal of obstetrics and gynecology. 2015 Jan:212(1):89.e1-5. doi: 10.1016/j.ajog.2014.06.055. Epub 2014 Jun 30
[PubMed PMID: 24992691]
[28]
Son M, Miller ES. Predicting preterm birth: Cervical length and fetal fibronectin. Seminars in perinatology. 2017 Dec:41(8):445-451. doi: 10.1053/j.semperi.2017.08.002. Epub 2017 Sep 19
[PubMed PMID: 28935263]
[29]
Ness A, Visintine J, Ricci E, Berghella V. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. American journal of obstetrics and gynecology. 2007 Oct:197(4):426.e1-7
[PubMed PMID: 17904989]
Level 1 (high-level) evidence
[30]
van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HCJ, Spaanderman MEA, Bloemenkamp KWM, Haak MC, Bolte AC, Bax CJ, Cornette JMJ, Duvekot JJ, Nij Bijvanck BWA, van Eyck J, Franssen MTM, Sollie KM, Vandenbussche FPHA, Woiski M, Grobman WA, van der Post JAM, Bossuyt PMM, Opmeer BC, Mol BWJ. Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor. Obstetrics and gynecology. 2014 Jun:123(6):1185-1192. doi: 10.1097/AOG.0000000000000229. Epub
[PubMed PMID: 24807328]
[31]
Abbott DS, Radford SK, Seed PT, Tribe RM, Shennan AH. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. American journal of obstetrics and gynecology. 2013 Feb:208(2):122.e1-6. doi: 10.1016/j.ajog.2012.10.890. Epub 2012 Nov 16
[PubMed PMID: 23164760]
[32]
Nikolova T, Uotila J, Nikolova N, Bolotskikh VM, Borisova VY, Di Renzo GC. Prediction of spontaneous preterm delivery in women presenting with premature labor: a comparison of placenta alpha microglobulin-1, phosphorylated insulin-like growth factor binding protein-1, and cervical length. American journal of obstetrics and gynecology. 2018 Dec:219(6):610.e1-610.e9. doi: 10.1016/j.ajog.2018.09.016. Epub 2018 Sep 18
[PubMed PMID: 30240653]
[33]
Dayal S, Jenkins SM, Hong PL. Preterm and Term Prelabor Rupture of Membranes (PPROM and PROM). StatPearls. 2025 Jan:():
[PubMed PMID: 30422483]
[34]
Gyamfi-Bannerman C, Thom EA. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. The New England journal of medicine. 2016 Aug 4:375(5):486-7. doi: 10.1056/NEJMc1605902. Epub
[PubMed PMID: 27518669]
[35]
Deshmukh US, Lundsberg LS, Pettker CM, Rouse DJ, Reddy UM. Neonatal outcomes by delivery indication after administration of antenatal late preterm corticosteroids. AJOG global reports. 2022 Nov:2(4):100097. doi: 10.1016/j.xagr.2022.100097. Epub 2022 Sep 15
[PubMed PMID: 36536839]
[36]
Kamath-Rayne BD, Rozance PJ, Goldenberg RL, Jobe AH. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now? American journal of obstetrics and gynecology. 2016 Oct:215(4):423-30. doi: 10.1016/j.ajog.2016.06.023. Epub 2016 Jun 21
[PubMed PMID: 27342043]
[37]
Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS. Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: Replaces SMFM Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. American journal of obstetrics and gynecology. 2021 Nov:225(5):B36-B42. doi: 10.1016/j.ajog.2021.07.023. Epub 2021 Aug 5
[PubMed PMID: 34363784]
[38]
Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstetrics and gynecology. 2017 Aug:130(2):e102-e109. doi: 10.1097/AOG.0000000000002237. Epub
[PubMed PMID: 28742678]
Level 3 (low-level) evidence
[39]
Stock SJ, Thomson AJ, Papworth S, Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74. BJOG : an international journal of obstetrics and gynaecology. 2022 Jul:129(8):e35-e60. doi: 10.1111/1471-0528.17027. Epub 2022 Feb 16
[PubMed PMID: 35172391]
[40]
Liauw J, Foggin H, Socha P, Crane J, Joseph KS, Burrows J, Lacaze-Masmonteil T, Jain V, Boutin A, Hutcheon J. Technical Update No. 439: Antenatal Corticosteroids at Late Preterm Gestation. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 2023 Jun:45(6):445-457.e2. doi: 10.1016/j.jogc.2022.12.006. Epub 2022 Dec 23
[PubMed PMID: 36572248]
[41]
Vogel JP, Ramson J, Darmstadt GL, Qureshi ZP, Chou D, Bahl R, Oladapo OT. Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. The Lancet. Global health. 2022 Dec:10(12):e1707-e1708. doi: 10.1016/S2214-109X(22)00434-X. Epub
[PubMed PMID: 36400080]
[42]
Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS, Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet (London, England). 2006 Jun 10:367(9526):1913-9
[PubMed PMID: 16765760]
Level 1 (high-level) evidence
[43]
Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, Coomarasamy A, Tobias A, Chou D, Oladapo OT, Price MJ, Morris K, Gallos ID. Tocolytics for delaying preterm birth: a network meta-analysis (0924). The Cochrane database of systematic reviews. 2022 Aug 10:8(8):CD014978. doi: 10.1002/14651858.CD014978.pub2. Epub 2022 Aug 10
[PubMed PMID: 35947046]
Level 1 (high-level) evidence
[44]
Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: a meta-analysis and decision analysis. Obstetrics and gynecology. 2009 Mar:113(3):585-594. doi: 10.1097/AOG.0b013e318199924a. Epub
[PubMed PMID: 19300321]
Level 1 (high-level) evidence
[45]
Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. American journal of obstetrics and gynecology. 2011 Feb:204(2):134.e1-20. doi: 10.1016/j.ajog.2010.11.038. Epub
[PubMed PMID: 21284967]
Level 1 (high-level) evidence
[46]
Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, Carbonne B. Calcium channel blockers for inhibiting preterm labour and birth. The Cochrane database of systematic reviews. 2014 Jun 5:2014(6):CD002255. doi: 10.1002/14651858.CD002255.pub2. Epub 2014 Jun 5
[PubMed PMID: 24901312]
Level 1 (high-level) evidence
[47]
Xiong Z, Pei S, Zhu Z. Four kinds of tocolytic therapy for preterm delivery: Systematic review and network meta-analysis. Journal of clinical pharmacy and therapeutics. 2022 Jul:47(7):1036-1048. doi: 10.1111/jcpt.13641. Epub 2022 Mar 18
[PubMed PMID: 35304748]
Level 1 (high-level) evidence
[48]
Vermillion ST, Scardo JA, Lashus AG, Wiles HB. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. American journal of obstetrics and gynecology. 1997 Aug:177(2):256-9; discussion 259-61
[PubMed PMID: 9290437]
[49]
Savage AH, Anderson BL, Simhan HN. The safety of prolonged indomethacin therapy. American journal of perinatology. 2007 Apr:24(4):207-13
[PubMed PMID: 17447185]
[50]
Hammers AL, Sanchez-Ramos L, Kaunitz AM. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis. American journal of obstetrics and gynecology. 2015 Apr:212(4):505.e1-13. doi: 10.1016/j.ajog.2014.10.1091. Epub 2014 Oct 30
[PubMed PMID: 25448524]
Level 1 (high-level) evidence
[51]
Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ (Clinical research ed.). 2012 Oct 9:345():e6226. doi: 10.1136/bmj.e6226. Epub 2012 Oct 9
[PubMed PMID: 23048010]
Level 1 (high-level) evidence
[52]
van Vliet EOG, Nijman TAJ, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, Porath MM, Woiski M, Bax CJ, Bloemenkamp KWM, Scheepers HCJ, Jacquemyn Y, Beek EV, Duvekot JJ, Franssen MTM, Papatsonis DN, Kok JH, van der Post JAM, Franx A, Mol BW, Oudijk MA. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial. Lancet (London, England). 2016 May 21:387(10033):2117-2124. doi: 10.1016/S0140-6736(16)00548-1. Epub 2016 Mar 2
[PubMed PMID: 26944026]
Level 1 (high-level) evidence
[53]
Duckitt K, Thornton S, O'Donovan OP, Dowswell T. Nitric oxide donors for treating preterm labour. The Cochrane database of systematic reviews. 2014 May 8:2014(5):CD002860. doi: 10.1002/14651858.CD002860.pub2. Epub 2014 May 8
[PubMed PMID: 24809331]
Level 1 (high-level) evidence
[54]
Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, Iams JD, Wapner RJ, Sorokin Y, Alexander JM, Harper M, Thorp JM Jr, Ramin SM, Malone FD, Carpenter M, Miodovnik M, Moawad A, O'Sullivan MJ, Peaceman AM, Hankins GD, Langer O, Caritis SN, Roberts JM, Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. The New England journal of medicine. 2008 Aug 28:359(9):895-905. doi: 10.1056/NEJMoa0801187. Epub
[PubMed PMID: 18753646]
Level 1 (high-level) evidence
[55]
Shepherd ES, Goldsmith S, Doyle LW, Middleton P, Marret S, Rouse DJ, Pryde P, Wolf HT, Crowther CA. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. The Cochrane database of systematic reviews. 2024 May 10:5(5):CD004661. doi: 10.1002/14651858.CD004661.pub4. Epub 2024 May 10
[PubMed PMID: 38726883]
Level 1 (high-level) evidence
[56]
Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. American journal of obstetrics and gynecology. 2009 Jun:200(6):595-609. doi: 10.1016/j.ajog.2009.04.005. Epub
[PubMed PMID: 19482113]
Level 1 (high-level) evidence
[58]
. Prevention of Early-onset Neonatal Group B Streptococcal Disease: Green-top Guideline No. 36. BJOG : an international journal of obstetrics and gynaecology. 2017 Nov:124(12):e280-e305. doi: 10.1111/1471-0528.14821. Epub 2017 Sep 13
[PubMed PMID: 28901693]
[59]
Fogarty M, Osborn DA, Askie L, Seidler AL, Hunter K, Lui K, Simes J, Tarnow-Mordi W. Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis. American journal of obstetrics and gynecology. 2018 Jan:218(1):1-18. doi: 10.1016/j.ajog.2017.10.231. Epub 2017 Oct 30
[PubMed PMID: 29097178]
Level 1 (high-level) evidence
[60]
Seidler AL, Aberoumand M, Hunter KE, Barba A, Libesman S, Williams JG, Shrestha N, Aagerup J, Sotiropoulos JX, Montgomery AA, Gyte GML, Duley L, Askie LM, iCOMP Collaborators. Deferred cord clamping, cord milking, and immediate cord clamping at preterm birth: a systematic review and individual participant data meta-analysis. Lancet (London, England). 2023 Dec 9:402(10418):2209-2222. doi: 10.1016/S0140-6736(23)02468-6. Epub 2023 Nov 14
[PubMed PMID: 37977169]
Level 1 (high-level) evidence
[61]
Chartrand L, Barrington KJ, Dodin P, Villeneuve A. Delayed cord clamping in preterm twin infants: a systematic review and meta-analysis. American journal of obstetrics and gynecology. 2024 Oct 28:():. pii: S0002-9378(24)01085-8. doi: 10.1016/j.ajog.2024.10.024. Epub 2024 Oct 28
[PubMed PMID: 39477050]
Level 1 (high-level) evidence
[62]
Chaudhary P, Priyadarshi M, Singh P, Chaurasia S, Chaturvedi J, Basu S. Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial. European journal of pediatrics. 2023 Aug:182(8):3701-3711. doi: 10.1007/s00431-023-05053-6. Epub 2023 Jun 6
[PubMed PMID: 37278737]
Level 1 (high-level) evidence
[63]
Mota P, Bø K. ACOG Committee Opinion No. 804: Physical Activity and Exercise During Pregnancy and the Postpartum Period. Obstetrics and gynecology. 2021 Feb 1:137(2):376. doi: 10.1097/AOG.0000000000004267. Epub
[PubMed PMID: 33481514]
Level 3 (low-level) evidence
[64]
Saccone G, Della Corte L, Cuomo L, Reppuccia S, Murolo C, Napoli FD, Locci M, Bifulco G. Activity restriction for women with arrested preterm labor: a randomized controlled trial. American journal of obstetrics & gynecology MFM. 2023 Aug:5(8):100954. doi: 10.1016/j.ajogmf.2023.100954. Epub 2023 Apr 18
[PubMed PMID: 37080296]
Level 1 (high-level) evidence
[65]
Fuchs IB, Henrich W, Osthues K, Dudenhausen JW. Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labor. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2004 Oct:24(5):554-7
[PubMed PMID: 15386604]
[66]
Crump C, Sundquist J, Sundquist K. Adverse Pregnancy Outcomes and Long-Term Mortality in Women. JAMA internal medicine. 2024 Jun 1:184(6):631-640. doi: 10.1001/jamainternmed.2024.0276. Epub
[PubMed PMID: 38619848]
[67]
Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, Walsh MC, Vohr BR, Stoll BJ, Carlo WA, Van Meurs KP, Rysavy MA, Patel RM, Merhar SL, Sánchez PJ, Laptook AR, Hibbs AM, Cotten CM, D'Angio CT, Winter S, Fuller J, Das A, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA. 2022 Jan 18:327(3):248-263. doi: 10.1001/jama.2021.23580. Epub
[PubMed PMID: 35040888]
[68]
Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG : an international journal of obstetrics and gynaecology. 2003 Apr:110 Suppl 20():8-16
[PubMed PMID: 12763105]
[69]
Moore T, Hennessy EM, Myles J, Johnson SJ, Draper ES, Costeloe KL, Marlow N. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ (Clinical research ed.). 2012 Dec 4:345():e7961. doi: 10.1136/bmj.e7961. Epub 2012 Dec 4
[PubMed PMID: 23212880]
[70]
Nelson DB, Lafferty A, Venkatraman C, McDonald JG, Eckert KM, McIntire DD, Spong CY. Association of Vaginal Progesterone Treatment With Prevention of Recurrent Preterm Birth. JAMA network open. 2022 Oct 3:5(10):e2237600. doi: 10.1001/jamanetworkopen.2022.37600. Epub 2022 Oct 3
[PubMed PMID: 36315147]
[71]
Conde-Agudelo A, Romero R. Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis. American journal of obstetrics and gynecology. 2022 Sep:227(3):440-461.e2. doi: 10.1016/j.ajog.2022.04.023. Epub 2022 Apr 20
[PubMed PMID: 35460628]
Level 1 (high-level) evidence